Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Operations: 2009-2025

Historic Cash from Operations for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $57.5 million.

  • Prestige Consumer Healthcare's Cash from Operations fell 17.64% to $57.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.4 million, marking a year-over-year increase of 0.18%. This contributed to the annual value of $251.5 million for FY2025, which is 1.04% up from last year.
  • According to the latest figures from Q3 2025, Prestige Consumer Healthcare's Cash from Operations is $57.5 million, which was down 27.24% from $79.0 million recorded in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Cash from Operations peaked at $79.0 million during Q2 2025, and registered a low of $48.1 million during Q2 2023.
  • Over the past 3 years, Prestige Consumer Healthcare's median Cash from Operations value was $62.5 million (recorded in 2023), while the average stood at $63.3 million.
  • Over the last 5 years, Prestige Consumer Healthcare's Cash from Operations had its largest YoY gain of 44.25% in 2025, and its largest YoY loss of 17.64% in 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Cash from Operations (Quarterly) stood at $66.3 million in 2021, then decreased by 17.13% to $54.9 million in 2022, then skyrocketed by 30.09% to $71.5 million in 2023, then dropped by 8.93% to $65.1 million in 2024, then declined by 17.64% to $57.5 million in 2025.
  • Its last three reported values are $57.5 million in Q3 2025, $79.0 million for Q2 2025, and $61.8 million during Q1 2025.